MedTrace Logo

Microwave Ablation of Resectable Liver Tumors

NCT00892255 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-04-02

No results posted yet for this study

Summary

The purpose of this protocol is to pathologically evaluate the destruction by microwave ablation of primary and metastatic liver tumors. The primary aim is to measure tissue destruction with the MedWaves Microwave Ablation/ Coagulation Ablation System.

Conditions

Interventions

DEVICE

Microwave Ablation

Tumor tissue from the liver is inter-operatively treated with the microwave ablation device to measure the destruction of tissue.

Sponsors & Collaborators

  • St. Joseph Hospital of Orange

    lead OTHER

Principal Investigators

  • Hisham El-Bayar, MD · St. Joseph Hospital of Orange

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00892255 on ClinicalTrials.gov